Literature DB >> 34008223

Macrofollicular variant follicular thyroid tumors are DICER1 mutated and exhibit distinct histological features.

C Christofer Juhlin1,2, Adam Stenman1,3,4, Jan Zedenius3,4.   

Abstract

AIMS: DICER1 germline mutations cause DICER1 syndrome, in which multinodular goitre is a common feature. Recently, somatic DICER1 mutations have been reported in sporadic thyroid carcinomas, of which the newly described macrofollicular variant of follicular thyroid carcinoma (MV-FTC) seems particularly enriched for this aberrancy. We report here histological and genetic findings in five follicular thyroid tumours with macrofollicular architecture (four carcinomas and one adenoma). METHODS AND
RESULTS: We have diagnosed five cases during a year-long period at the Karolinska University Hospital, a tertiary thyroid cancer center with a catchment area of approximately 2.3 million inhabitants. Tumour DNA was interrogated using a commercially available massive parallel sequencing platform. All cases were female patients, ranging from 13 to 33 years at surgery. A single patient was a DICER1 syndrome carrier; the others were sporadic cases. All tumours displayed a macrofollicular architecture with a broad capsule. The MV-FTCs displayed capsular invasion, but never vascular invasion. Areas with degenerative changes (microinfarctions) were noted in all cases, and focal papillary growth was observed in the majority. The Ki-67 proliferation index was always above 4%. All cases displayed DICER1 gene mutations, of which four of five cases displayed RNase IIIb hot-spot missense mutations adjoined by a second, deleterious variant in three of five tumouurs.
CONCLUSIONS: Macrofollicular variants of follicular thyroid tumours are predominantly found in younger females and are strongly linked to somatic DICER1 gene mutations. Histological features such as a broad tumorous capsule, focal infarctions and areas with papillae could constitute clues prompting further genetic analyses.
© 2021 The Authors. Histopathology published by John Wiley & Sons Ltd.

Entities:  

Keywords:  DICER1; follicular thyroid carcinoma; histology; macrofollicular variant; mutation

Mesh:

Substances:

Year:  2021        PMID: 34008223     DOI: 10.1111/his.14416

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

Review 1.  Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: DICER1-Related Thyroid Tumors.

Authors:  Madeline Sauer; Justine A Barletta
Journal:  Head Neck Pathol       Date:  2022-03-21

Review 2.  Overview of the 2022 WHO Classification of Thyroid Neoplasms.

Authors:  Zubair W Baloch; Sylvia L Asa; Justine A Barletta; Ronald A Ghossein; C Christofer Juhlin; Chan Kwon Jung; Virginia A LiVolsi; Mauro G Papotti; Manuel Sobrinho-Simões; Giovanni Tallini; Ozgur Mete
Journal:  Endocr Pathol       Date:  2022-03-14       Impact factor: 3.943

3.  Expanding the spectrum of thyroid carcinoma with somatic DICER1 mutation: a survey of 829 thyroid carcinomas using MSK-IMPACT next-generation sequencing platform.

Authors:  Charles A Ghossein; Snjezana Dogan; Nada Farhat; Iñigo Landa; Bin Xu
Journal:  Virchows Arch       Date:  2021-09-27       Impact factor: 4.064

Review 4.  Emerging Biomarkers in Thyroid Practice and Research.

Authors:  Shipra Agarwal; Andrey Bychkov; Chan-Kwon Jung
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

5.  Synchronous lateral lymph node metastases from papillary and follicular thyroid carcinoma: case report and review of the literature.

Authors:  Adam Stenman; Magnus Kjellman; Jan Zedenius; C Christofer Juhlin
Journal:  Thyroid Res       Date:  2022-02-04

6.  Whole-genome Sequencing of Follicular Thyroid Carcinomas Reveal Recurrent Mutations in MicroRNA Processing Subunit DGCR8.

Authors:  Johan O Paulsson; Nima Rafati; Sebastian DiLorenzo; Yi Chen; Felix Haglund; Jan Zedenius; C Christofer Juhlin
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 5.958

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.